TearSolutions, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tearsolutions.com
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Phase 1
Completed
- Conditions
- Primary Sjögren SyndromeDry Eye
- Interventions
- Drug: 0.005% LacripepDrug: 0.01% LacripepDrug: Placebo
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- TearSolutions, Inc.
- Target Recruit Count
- 204
- Registration Number
- NCT03226444
- Locations
- 🇺🇸
Bruce A. Segal, MD PA Private Practice, Delray Beach, Florida, United States
🇺🇸Orange County Ophthalmology, Garden Grove, California, United States
🇺🇸Lugene Eye Institute, Glendale, California, United States
© Copyright 2025. All Rights Reserved by MedPath